Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut Takeda Pharmaceutical (NYSE:TAK) reported fiscal 2025 results that management described as solid despite pressure from generic ...

This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...

Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...

Johnson & Johnson's JNJ Immunology franchise remains one of its most important businesses, even as it undergoes a transition ...

Osteoarthritis, far from being “simply wear and tear,” demands a multifaceted management strategy, according to a speaker at ...

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated C-reactive protein levels, may benefit from guselkumab plus golimumab therapy.

RA can affect more than your joints—here are the symptoms doctors say are often overlooked.

Learn how to manage hereditary angioedema (HAE) attacks with on-demand medications, from identifying early symptoms to ...

Objectives To evaluate the long-term outcomes, clinical phenotypes and factors associated with complications in Still’s ...